🔬 A new study on Lactiplantibacillus plantarum Lp-G18 has been published in the prestigious international peer-reviewed journal Food Research International (Impact Factor = 8):

① Lp-G18 modulates the gut microbiota and promotes elevated production of the key tryptophan metabolite IAA (Indole-3-Acetic Acid), improving intrahepatic cholestasis via the gut-liver axis.

② The metabolite IAA is strongly correlated with improvements in liver injury and demonstrates multiple benefits, including liver protection, anti-inflammation, enhanced metabolism, and mood improvement. As no clinical studies on direct oral IAA administration currently exist, this research on Lp-G18 fills an important gap in the field — offering a novel approach to liver health.

💡 As a Flora-Focus® star strain from BioGrowing, Lactiplantibacillus plantarum Lp-G18 has received 4 international industry awards: Top 3 at the NutraIngredients Asia Awards, Ringier Technology Innovation Award 2024, Hi&Fi Asia-China Food Tech Innovation Award, and European Specialist Sports Nutrition Awards 2024. The strain is further supported by 1 granted patent and 6 scientific studies (including 2 clinical trials), demonstrating significant health benefits across lipid reduction, immune modulation, H. pylori inhibition, and anti-aging.